Role of the CAG repeat polymorphism of the androgen receptor gene in polycystic ovary syndrome (PCOS).

BACKGROUND Polycystic ovary syndrome (PCOS) is a frequent heterogenic disorder with a familial background. Androgenic effects, determining the clinical features of the syndrome, are mediated by the androgen receptor (AR), whose activity is modulated by a genetic polymorphism. We investigated the role of the CAG repeat polymorphism of the androgen receptor in PCOS. METHODS In the infertility unit of a university clinic, 72 PCOS patients were compared with 179 ovulatory controls undergoing a standardized diagnostic work-up. The number of CAG repeats was determined by PCR, labelling with IR-800 and PAGE. X-chromosome inactivation was assessed by a methylation-sensitive assay. RESULTS Compared to controls, PCOS patients displayed a shorter mean CAG repeat length, encoding for higher AR activity (P=0.001). CAG repeat length correlated inversely with oligomenorrhea, a central androgen dependent feature of the syndrome (P=0.005). In a binomial regression analysis including BMI, LH and free testosterone, CAG repeat length was identified as an independent risk factor for PCOS (P=0.002). CONCLUSIONS The CAG repeat polymorphism could constitute one of the genetic factors modulating the syndrome's phenotype, contributing to its clinical heterogeneity and associated metabolic consequences.

[1]  A. Tsatsoulis,et al.  Review: Fetal Programming of Polycystic Ovary Syndrome by Androgen Excess — Evidence from Experimental, Clinical and Genetic Association Studies , 2014 .

[2]  L. Haeberle,et al.  The different phenotypes of polycystic ovary syndrome: no advantages for identifying women with aggravated insulin resistance or impaired lipids. , 2011, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[3]  S. Moon,et al.  Androgen receptor gene CAG repeat polymorphism in women with polycystic ovary syndrome. , 2008, Fertility and sterility.

[4]  M. P. Perme,et al.  Androgen receptor gene (CAG)n polymorphism in patients with polycystic ovary syndrome. , 2008, Fertility and sterility.

[5]  G. Ning,et al.  Androgen receptor gene CAGn trinucleotide repeats polymorphism in Chinese women with polycystic ovary syndrome , 2008, Endocrine.

[6]  K. Taylor,et al.  Association of androgen receptor CAG repeat polymorphism and polycystic ovary syndrome. , 2008, The Journal of clinical endocrinology and metabolism.

[7]  A. Tsatsoulis,et al.  The role of sex hormone-binding globulin and androgen receptor gene variants in the development of polycystic ovary syndrome. , 2008, Human reproduction.

[8]  D. Deforce,et al.  Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome , 2008, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[9]  T. Maltaris,et al.  Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS. , 2007, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[10]  M. McCarthy,et al.  Metabolic characteristics of women with polycystic ovaries and oligo‐amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome , 2007, Clinical endocrinology.

[11]  D. Dewailly,et al.  Oligoanovulation with polycystic ovaries but not overt hyperandrogenism. , 2006, The Journal of clinical endocrinology and metabolism.

[12]  A. Pfeiffer,et al.  The androgen receptor CAG repeat modifies the impact of testosterone on insulin resistance in women with polycystic ovary syndrome. , 2006, European journal of endocrinology.

[13]  A. Tsatsoulis,et al.  Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. , 2006, The Journal of clinical endocrinology and metabolism.

[14]  M. Beckmann,et al.  Is it necessary to measure free testosterone to assess hyperandrogenemia in women? The role of calculated free and bioavailable testosterone. , 2006, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[15]  R. Azziz Diagnosis of Polycystic Ovarian Syndrome: The Rotterdam Criteria Are Premature , 2006 .

[16]  M. Urbanek,et al.  Candidate gene region for polycystic ovary syndrome on chromosome 19p13.2. , 2005, The Journal of clinical endocrinology and metabolism.

[17]  A. Pinchera,et al.  Androgen receptor polymorphism (CAG repeats) and androgenicity , 2005, Clinical endocrinology.

[18]  D. Abbott,et al.  Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? , 2005, Human reproduction update.

[19]  R. Voutilainen,et al.  Androgen receptor gene CAG length polymorphism in women with polycystic ovary syndrome. , 2005, Fertility and sterility.

[20]  J. L. San Millán,et al.  The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. , 2005, Endocrine reviews.

[21]  V. Burke,et al.  Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management , 2005, Clinical endocrinology.

[22]  E. Nieschlag,et al.  X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients. , 2004, The Journal of clinical endocrinology and metabolism.

[23]  D. Ehrmann Polycystic ovary syndrome. , 2004, The New England journal of medicine.

[24]  Ricardo Azziz,et al.  0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(6):2745–2749 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-032046 The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected , 2022 .

[25]  D. Dewailly,et al.  The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. , 2004, Human reproduction update.

[26]  K. Taylor,et al.  Androgen excess in women: experience with over 1000 consecutive patients. , 2004, The Journal of clinical endocrinology and metabolism.

[27]  Didier Dewailly,et al.  Ultrasound assessment of the polycystic ovary: international consensus definitions. , 2003, Human reproduction update.

[28]  Jarmo Jääskeläinen,et al.  Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism. , 2003, The Journal of clinical endocrinology and metabolism.

[29]  R. Junker,et al.  The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males , 2001, Clinical endocrinology.

[30]  M. McCarthy,et al.  Candidate genes in polycystic ovary syndrome. , 2001, Human reproduction update.

[31]  P. Björntorp,et al.  Polymorphisms of the Androgen Receptor Gene and the Estrogen Receptor ␤ Gene Are Associated with Androgen Levels in Women* , 2022 .

[32]  E. Yong,et al.  Androgen receptor gene CAG trinucleotide repeats in anovulatory infertility and polycystic ovaries. , 2000, The Journal of clinical endocrinology and metabolism.

[33]  J. L. San Millán,et al.  The role of the CAG repeat polymorphism in the androgen receptor gene and of skewed X-chromosome inactivation, in the pathogenesis of hirsutism. , 2000, The Journal of clinical endocrinology and metabolism.

[34]  H. Mason Function of the polycystic ovary , 2000, Human fertility.

[35]  G. Chrousos,et al.  Androgen receptor-mediated hypersensitivity to androgens in women with nonhyperandrogenic hirsutism: skewing of X-chromosome inactivation. , 1999, The Journal of clinical endocrinology and metabolism.

[36]  C. Bondy,et al.  Androgens stimulate early stages of follicular growth in the primate ovary. , 1998, The Journal of clinical investigation.

[37]  A. Dunaif,et al.  Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. , 1997, Endocrine reviews.

[38]  S. Hillier,et al.  Role of androgens in follicle maturation and atresia. , 1997, Bailliere's clinical obstetrics and gynaecology.

[39]  M. Leppert,et al.  Heritability of X chromosome--inactivation phenotype in a large family. , 1996, American journal of human genetics.

[40]  S. Franks,et al.  Polycystic ovary syndrome. , 1995, Archives of disease in childhood.

[41]  S. Franks,et al.  Hypersecretion of androstenedione by isolated thecal cells from polycystic ovaries. , 1994, The Journal of clinical endocrinology and metabolism.

[42]  N. Chamberlain,et al.  The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. , 1994, Nucleic acids research.

[43]  R. Legro,et al.  Size Polymorphisms of the Androgen Receptor Among Female Hispanics and Correlation With Androgenic Characteristics , 1994, Obstetrics and gynecology.

[44]  L. Jin,et al.  Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups. , 1992, Genomics.

[45]  S. Franks,et al.  Polycystic Ovaries A Common Finding in Normal Women , 1988 .

[46]  J. Wadsworth,et al.  POLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN , 1988, The Lancet.

[47]  Chawnshang Chang,et al.  Molecular cloning of human and rat complementary DNA encoding androgen receptors. , 1988, Science.

[48]  J. Price,et al.  MULTIFOLLICULAR OVARIES: CLINICAL AND ENDOCRINE FEATURES AND RESPONSE TO PULSATILE GONADOTROPIN RELEASING HORMONE , 1985, The Lancet.

[49]  D. Ferriman,et al.  Clinical assessment of body hair growth in women. , 1961, The Journal of clinical endocrinology and metabolism.

[50]  M. Rizzo,et al.  Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism. , 2006, The Journal of clinical endocrinology and metabolism.

[51]  B. Fauser,et al.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). , 2004, Human reproduction.

[52]  T. Hickey,et al.  The androgen receptor CAG repeat polymorphism and X-chromosome inactivation in Australian Caucasian women with infertility related to polycystic ovary syndrome. , 2002, The Journal of clinical endocrinology and metabolism.

[53]  F. Bischoff,et al.  Evidence of skewed X-chromosome inactivation in 47,XXY and 48,XXYY Klinefelter patients. , 2001, American journal of medical genetics.

[54]  M. Lyon,et al.  Some milestones in the history of X-chromosome inactivation. , 1992, Annual review of genetics.

[55]  H. Zoghbi,et al.  Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. , 1992, American journal of human genetics.